iTRAQ proteomic analysis of extracellular matrix remodeling in aortic valve disease

Autors de IIS La Fe

• 

  Esther Roselló Lletí

  Autor

• Jose Miguel Rivera Otero

  Autor

Autors aliens a IIS La Fe

• Martin-Rojas T
• Mourino-Alvarez L
• Alonso-Orgaz S
• Calvo E
• Lopez-Almodovar LF
• Padial LR
• Lopez JA
• de la Cuesta F
• Barderas MG

Grups d'Investigació

• Grupo de Investigación Clínica y Traslacional en Cardiología

  

  Investigador Principal

  Esther Roselló Lletí

Abstract

Degenerative aortic stenosis (AS) is the most common worldwide cause of valve replacement. The aortic valve is a thin, complex, layered connective tissue with compartmentalized extracellular matrix (ECM) produced by specialized cell types, which directs blood flow in one direction through the heart. There is evidence suggesting remodeling of such ECM during aortic stenosis development. Thus, a better characterization of the role of ECM proteins in this disease would increase our understanding of the underlying molecular mechanisms. Aortic valve samples were collected from 18 patients which underwent aortic valve replacement (50% males, mean age of 74 years) and 18 normal control valves were obtained from necropsies (40% males, mean age of 69 years). The proteome of the samples was analyzed by 2D-LC MS/MS iTRAQ methodology. The results showed an altered expression of 13 ECM proteins of which 3 (biglycan, periostin, prolargin) were validated by Western blotting and/or SRM analyses. These findings are substantiated by our previous results demonstrating differential ECM protein expression. The present study has demonstrated a differential ECM protein pattern in individuals with AS, therefore supporting previous evidence of a dynamic ECM remodeling in human aortic valves during AS development.

Keywords

• LEUCINE-RICH REPEAT; OSTEOBLAST-SPECIFIC FACTOR; TOLL-LIKE RECEPTOR-4; ATHEROSCLEROTIC PLAQUES; INTERSTITIAL-CELLS; OXIDIZED LDL; PERIOSTIN; STENOSIS; BIGLYCAN; PROTEIN